Comment on: The ORIGIN Trial Investigators. Characteristics Associated With Maintenance of Mean A1C  | Zendy

Katherine Esposito | Zendy; Dario Giugliano | Zendy

Open Access

Comment on: The ORIGIN Trial Investigators. Characteristics Associated With Maintenance of Mean A1C <6.5% in People With Dysglycemia in the ORIGIN Trial. Diabetes Care 2013;36:2915-2922

Author(s) -

Katherine Esposito,

Dario Giugliano

Publication year - 2013

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc13-1167

Subject(s) - medicine , diabetes mellitus , clinical trial , randomized controlled trial , medline , intensive care medicine , gerontology , endocrinology , political science , law

In their recently published Outcome Reduction with Initial Glargine Intervention (ORIGIN) trial (1), the investigators found that basal insulin glargine started early in the natural history of dysglycemia can maintain glycemic control near baseline levels for the whole study length. This trial is important for the size (12,537 individuals), geography (40 countries), and follow-up (up to 5 years). During glargine treatment, the percentage of diabetic patients achieving A1C <7.0% (53 mmol/mol) was 88% at 1 year and 77% at 5 years, and the percentage achieving A1C <6.5% (48 mmol/mol) was 74% at 1 year and 60% after 5 years. These percentages of success …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research